Sodium Butyrate Ameliorates l-Arginine-Induced Pancreatitis and Associated Fibrosis in Wistar Rat: Role of Inflammation and Nitrosative Stress

Journal of Biochemical and Molecular Toxicology

Volumn 29, Issue 8, 2015, Pages 349-359

  Kanika, Gayathri ^a   Khan, Sabbir ^a   Jena, Gopabandhu ^a  

^a NATIONAL INSTITUTE OF PHARMACEUTICAL EDUCATION AND RESEARCH NIPER   (India)

Author keywords

Chronic pancreatitis; HDAC inhibitor; l Arginine; Pancreatic fibrosis; Sodium butyrate

Indexed keywords

3 NITROTYROSINE; ALPHA SMOOTH MUSCLE ACTIN; ARGININE; BUTYRIC ACID; INDUCIBLE NITRIC OXIDE SYNTHASE; INTERLEUKIN 1BETA; 3-NITROTYROSINE; NOS2 PROTEIN, HUMAN; TYROSINE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CHRONIC PANCREATITIS; CONTROLLED STUDY; CYSTIC FIBROSIS; DNA DAMAGE; DRUG EFFECT; HISTOPATHOLOGY; INVESTIGATIVE PROCEDURES; MALE; NITROSATIVE STRESS; NONHUMAN; OXIDATIVE STRESS; PANCREAS INJURY; PROTEIN EXPRESSION; RAT; WISTAR RAT; ANALOGS AND DERIVATIVES; ANIMAL; DOWN REGULATION; DRUG EFFECTS; FIBROSIS; GENETICS; INFLAMMATION; PANCREAS; PANCREATITIS; PATHOLOGY;

RATTUS; RATTUS NORVEGICUS;

ANIMALS; ARGININE; BUTYRIC ACID; DOWN-REGULATION; FIBROSIS; INFLAMMATION; NITRIC OXIDE SYNTHASE TYPE II; PANCREAS; PANCREATITIS; RATS, WISTAR; TYROSINE;

EID: 84938747304     PISSN: 10956670     EISSN: 10990461     Source Type: Journal    
DOI: 10.1002/jbt.21698     Document Type: Article

References (49)

1. Schneider A, Whitcomb DC, Singer MV. Animal models in alcoholic pancreatitis-what can we learn? Pancreatology 2002;2:189-203.
2. Witt H, Apte MV, Keim V, Wilson JS. Chronic pancreatitis: challenges and advances in pathogenesis, genetics, diagnosis, and therapy. Gastroenterology 2007;132:1557-1573.
3. Masamune A, Watanabe T, Kikuta K, Shimosegawa T. Roles of pancreatic stellate cells in pancreatic inflammation and fibrosis. Clin Gastroenterol Hepatol 2009;7:S48-S54.
4. Gonzalez AM, Garcia T, Samper E, Rickmann M, Vaquero EC, Molero X. Assessment of the protective effects of oral tocotrienols in arginine chronic-like pancreatitis. Am J Physiol Gastrointest Liver Physiol 2011;301:G846-G855.
5. Richmond TJ, Davey CA. The structure of DNA in the nucleosome core. Nature 2003;423:145-150.
6. Haumaitre C, Lenoir O, Scharfmann R. Histone deacetylase inhibitors modify pancreatic cell fate determination and amplify endocrine progenitors. Mol Cell Biol 2008;28:6373-6383.
7. Dokmanovic M, Clarke C, Marks PA. Histone deacetylase inhibitors: overview and perspectives. Mol Cancer Res 2007;5:981-989.
8. Kuo MH, Allis CD. Roles of histone acetyltransferases and deacetylases in gene regulation. BioEssays 1998;20:615-626.
9. Tse C, Sera T, Wolffe AP, Hansen JC. Disruption of higher-order folding by core histone acetylation dramatically enhances transcription of nucleosomal arrays by RNA polymerase III. Mol Cell Biol 1998;18:4629-4638.
10. Van Beneden K, Mannaerts I, Pauwels M, Van den Branden C, van Grunsven LA. HDAC inhibitors in experimental liver and kidney fibrosis. Fibrogenesis Tissue Repair 2013;6:1.
11. Haumaitre C, Lenoir O, Scharfmann R. Directing cell differentiation with small-molecule histone deacetylase inhibitors: the example of promoting pancreatic endocrine cells. Cell Cycle 2009;8:536-544.
12. Bulow R, Fitzner B, Sparmann G, Emmrich J, Liebe S, Jaster R. Antifibrogenic effects of histone deacetylase inhibitors on pancreatic stellate cells. Biochem Pharmacol 2007;74:1747-1757.
13. Mattace Raso G, Simeoli R, Russo R, Iacono A, Santoro A, Paciello O, Ferrante MC, Canani RB, Calignano A, Meli R. Effects of sodium butyrate and its synthetic amide derivative on liver inflammation and glucose tolerance in an animal model of steatosis induced by high fat diet. PLoS One 2013;8:e68626.
14. Mishiro T, Kusunoki R, Otani A, Ansary MM, Tongu M, Harashima N, Yamada T, Sato S, Amano Y, Itoh K, Ishihara S, Kinoshita Y. Butyric acid attenuates intestinal inflammation in murine DSS-induced colitis model via milk fat globule-EGF factor 8. Lab Invest 2013;93:834-843.
15. Rahman I, Marwick J, Kirkham P. Redox modulation of chromatin remodeling: impact on histone acetylation and deacetylation, NF-kappaB and pro-inflammatory gene expression. Biochem Pharmacol 2004;68:1255-1267.
16. Khan S, Jena G, Tikoo K. Sodium valproate ameliorates diabetes-induced fibrosis and renal damage by the inhibition of histone deacetylases in diabetic rat. Exp Mol Pathol 2015;98(2):230-239.
17. Khan S, Jena G. Sodium butyrate, a HDAC inhibitor ameliorates eNOS, iNOS and TGF-beta1-induced fibrogenesis, apoptosis and DNA damage in the kidney of juvenile diabetic rats. Food Chem Toxicol 2014;73:127-139.
18. Davie JR. Inhibition of histone deacetylase activity by butyrate. J Nutr 2003;133:2485s-2493s.
19. Candido EP, Reeves R, Davie JR. Sodium butyrate inhibits histone deacetylation in cultured cells. Cell 1978;14:105-113.
20. Khan S, Jena GB. Protective role of sodium butyrate, a HDAC inhibitor on beta-cell proliferation, function and glucose homeostasis through modulation of p38/ERK MAPK and apoptotic pathways: study in juvenile diabetic rat. Chem Biol Interact 213:1-12.
21. Säemann MD, Böhmig GA, Osterreicher CH, Burtscher H, Parolini O, Diakos C, Stöckl J, Hörl WH, Zlabinger GJ. Anti-inflammatory effects of sodium butyrate on human monocytes: potent inhibition of IL-12 and up-regulation of IL-10 production. FASEB J 2000;14:2380-2382.
22. Khan S, Jena GB, Tikoo KB, Kumar V. Valproate attenuates the proteinuria, podocyte and renal injury by facilitating autophagy and inactivation of NF-κB/iNOS signaling in diabetic rat. Biochimie 2015;110:1-16.
23. Aher J, Khan S, Jain S, Tikoo K, Jena G. Valproate ameliorates thioacetamide-induced fibrosis by hepatic stellate cell inactivation. Hum Exp Toxicol 2015;34:44-55.
24. Khan S, Jena GB. Effect of sodium valproate on the toxicity of cyclophosphamide in the testes of mice: influence of pre- and post-treatment schedule. Toxicol Int 2013;20:68-76.
25. Bredt DS, Snyder SH. Nitric oxide: a physiologic messenger molecule. Annu Rev Biochem 1994;63:175-195.
26. Khan S, Ahmad T, Parekh CV, Trivedi PP, Kushwaha S, Jena G. Investigation on sodium valproate induced germ cell damage, oxidative stress and genotoxicity in male Swiss mice. Reprod Toxicol 2011;32:385-394.
27. Khan S, Jena G. Sodium valproate, a histone deacetylase inhibitor ameliorates cyclophosphamide-induced genotoxicity and cytotoxicity in the colon of mice. J Basic Clin Physiol Pharmacol 2014;25(4):329-339.
28. Lowry OH, Rosebrough NJ, Farr AL, Randall RJ. Protein measurement with the Folin phenol reagent. J Biol Chem 1951;193:265-275.
29. Namoju RC, Khan S, Patel RS, Shera FY, Trivedi PP, Kushwaha S, Jena GB. Pre-pubertal exposure of cytarabine-induced testicular atrophy, impaired spermatogenesis and germ cell DNA damage in SD rats. Toxicol Mech Methods 2014;24:703-712.
30. McLoughlin MF, Graham DA, Norris A, Matthews D, Foyle L, Rowley HM, Jewhurst H, MacPhee J, Todd D. Virological, serological and histopathological evaluation of fish strain susceptibility to experimental infection with salmonid alphavirus. Dis Aquat Organ 2006;72:125-133.
31. Yadav L, Khan S, Shekh K, Jena GB. Influence of 3-aminobenzamide, an inhibitor of poly(ADP-ribose)polymerase, in the evaluation of the genotoxicity of doxorubicin, cyclophosphamide and zidovudine in female mice. Mutat Res Genet Toxicol Environ Mutagen 2014;770:6-15.
32. Shekh K, Khan S, Jena G, Kansara BR, Kushwaha S. 3-Aminobenzamide-a PARP inhibitor enhances the sensitivity of peripheral blood micronucleus and comet assays in mice. Toxicol Mech Methods 2014;24:332-341.
33. Ahmad T, Shekh K, Khan S, Vikram A, Yadav L, Parekh CV, Jena GB. Pretreatment with valproic acid, a histone deacetylase inhibitor, enhances the sensitivity of the peripheral blood micronucleus assay in rodents. Mutat Res 2013;751:19-26.
34. Kotunia A, Woliński J, Laubitz D, Jurkowska M, Romé V, Guilloteau P, Zabielski R. Effect of sodium butyrate on the small intestine development in neonatal piglets fed [correction of feed] by artificial sow. J Physiol Pharmacol 2004;55(Suppl 2):59-68.
35. Yin L, Laevsky G, Giardina C. Butyrate suppression of colonocyte NF-kB activation and cellular proteasome activity. J Biol Chem 2001;276:44641-44646.
36. Huang L, Cao J. The Protective effects of Shen-Fu injection on experimental acute pancreatitis in a rat model. Oxid Med Cell Longev 2014;2014(2014): Article ID 248786, 1-7.
37. Buchwalow I, Schnekenburger J, Tiemann K, Samoilova V, Bankfalvi A, Poremba C, Schleicher C, Neumann J, Boecker W. L-Arginine-NO-cGMP signalling pathway in pancreatitis. Sci Rep 2013;3:1899.
38. Varga IS, Matkovics B, Czako L, Hai DQ, Kotorman M, Takacs T, Sasvari M. Oxidative stress changes in L-arginine-induced pancreatitis in rats. Pancreas 1997;14:355-359.
39. Kui B, Balla Z, Végh ET, Pallagi P, Venglovecz V, Iványi B, Takács T, Hegyi P, Rakonczay Z Jr. Recent advances in the investigation of pancreatic inflammation induced by large doses of basic amino acids in rodents. Lab Invest 2014;94:138-149.
40. Lala PK, Chakraborty C. Role of nitric oxide in carcinogenesis and tumour progression. Lancet Oncol 2001;2:149-156.
41. Hensley K, Robinson KA, Gabbita SP, Salsman S, Floyd RA. Reactive oxygen species, cell signaling, and cell injury. Free Radic Biol Med 2000;28:1456-1462.
42. Sasahara Y, Mutoh M, Takahashi M, Fukuda K, Tanaka N, Sugimura T, Wakabayashi K. Suppression of promoter-dependent transcriptional activity of inducible nitric oxide synthase by sodium butyrate in colon cancer cells. Cancer Lett 2002;177:155-161.
43. Vinolo MA, Rodrigues HG, Nachbar RT, Curi R. Regulation of inflammation by short chain fatty acids. Nutrients 2011;3:858-876.
44. Hofseth LJ. Nitric oxide as a target of complementary and alternative medicines to prevent and treat inflammation and cancer. Cancer Lett 2008;268:10-30.
45. Apte MV, Wilson JS. Alcohol-induced pancreatic injury. Best Pract Res Clin Gastroenterol 2003;17:593-612.
46. Omary MB, Lugea A, Lowe AW, Pandol SJ. The pancreatic stellate cell: a star on the rise in pancreatic diseases. J Clin Invest 2007;117:50-59.
47. Cooke MS, Evans MD, Dizdaroglu M, Lunec J. Oxidative DNA damage: mechanisms, mutation, and disease. FASEB J 2003;17:1195-1214.
48. Maremanda KP, Khan S, Jena G. Zinc protects cyclophosphamide-induced testicular damage in rat: involvement of metallothionein, tesmin and Nrf2. Biochem Biophys Res Commun 2014;445:591-596.
49. Bonnotte B, Favre N, Reveneau S, Micheau O, Droin N, Garrido C, Fontana A, Chauffert B, Solary E, Martin F. Cancer cell sensitization to fas-mediated apoptosis by sodium butyrate. Cell Death Differ 1998;5:480-487.